Redtree

Red Tree Venture Capital is a life sciences-focused venture capital firm that partners with pioneering scientists and entrepreneurs to build world-class biotechnology companies. Founded in 2020 and based in Redwood City, California, the firm primarily targets early-stage investments in oncology, neurology, and immunology, with a strong emphasis on innovation emerging from premier West Coast academic institutions. Red Tree's investment strategy is built on four pillars: a West Coast-centric focus, early-stage bias (Seed and Series A), a commitment to first-in-class or best-in-class therapeutics, and deep expertise in its core therapeutic areas. The firm manages a diverse portfolio of companies developing transformative treatments, including cell therapies, antibody-drug conjugates, and neuromodulation systems.